Effectiveness and safety of antiplatelet therapy in stroke recurrence prevention in patients with liver cirrhosis: a 2-year follow-up study-Reference-Cited by-同舟云学术

Effectiveness and safety of antiplatelet therapy in stroke recurrence prevention in patients with liver cirrhosis: a 2-year follow-up study

Author:

Chen Chung-Yu¹,Lee Kun-Tai²,Lee Charles Tzu-Chi³,Lai Wen-Ter⁴,Huang Yaw-Bin⁵⁶

Affiliation:

1. School of Pharmacy; Kaohsiung Medical University; Kaohsiung Taiwan

2. Division of Cardiology, Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Taiwan

3. Department of Public Health; Kaohsiung Medical University; Kaohsiung Taiwan

4. Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Taiwan

5. Graduate Institute of Clinical Pharmacy; Kaohsiung Medical University; Kaohsiung Taiwan

6. Department of Pharmacy; Kaohsiung Medical University Hospital; Kaohsiung Taiwan

Funder

National Science Council

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

Reference28 articles.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Anticoagulants and Antiplatelet Agents in Cirrhosis;Pharmacotherapy for Liver Cirrhosis and Its Complications;2022